Showing results (1211-1220 of 1,479) with videos related to

Sort By:
Pageof 148
Plos One|April 25, 2015
Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In VitroElisangela Oliveira Freitas, Dirlei Nico, Rong Guan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancerH Sasano, T J Anderson, S G Silverberg, et al.
The Journal of Biological Chemistry|February 26, 2004
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic functionWuxian Shi, Li-Min Ting, Gregory A Kicska, et al.
Surgery|November 26, 2015
Survival of patients with resectable pancreatic cancer who received neoadjuvant therapyKathleen K Christians, Jonathan W Heimler, Ben George, et al.
Annals of Surgery|May 14, 2020
Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal AdenocarcinomaRaju Kandimalla, Tadanobu Shimura, Saurav Mallik, et al.
Biophysical Journal|February 13, 2024
Long-distance tmFRET using bipyridyl- and phenanthroline-based ligandsSharona E Gordon, Eric G B Evans, Shauna C Otto, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2011
Development of steroid signaling pathways during primordial follicle formation in the human fetal ovaryPaul A Fowler, Richard A Anderson, Philippa T Saunders, et al.
Cancer|February 22, 2007
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a targetE Ramsay Camp, Anthony Yang, Mike J Gray, et al.
Annals of Surgical Oncology|June 25, 2011
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trialMatthew H G Katz, Robert Wolff, Christopher H Crane, et al.
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Pageof 148